¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25
±³À°ÀÏÀÚ : 2018-11-25
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°­´ç(B3)  
±³À°ÁÖÁ¦ : Konkuk Live Symposium: APECS, 2018 
ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú  
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : apecsmeeting@gmail.com      
±³À°Á¾·ù : ¿µ»óÀÇÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-25  09:00~09:10 What are common missing anatomies in US examination for venous disease?  À̰溹(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11-25  09:10~09:20 Which US equipment can be useful in venous clinics?  ±èÇâ°æ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-25  09:20~09:50 Live Case 1. : Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  09:50~10:00 How to improve US imaging quality during the endovenous procedure  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11-25  10:00~10:10 What are we missing when physicians handle US?  ±ÇÁö¿µ(ij³íÄÚ¸®¾Æ) 
±³À°½Ã°£ 11-25  10:10~10:20 Be the expert for US: How to obtain a license for US  È²Á¤±â(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-25  10:20~10:30 APECS meet IVDT symposium : Which benefits can IVDT give us?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
È޽Ġ11-25  10:30~10:50 Coffee break  () 
±³À°½Ã°£ 11-25  10:50~11:05 Current trends for varicose vein treatment in Europe  Tibor Balazs(Medissimo Hospital Bratislava, Slovakia) 
±³À°½Ã°£ 11-25  11:05~11:15 EVLT is not a loser: Still developing and excellent result  ¾È»óÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-25  11:15~11:25 Recurrent CVI after surgery: Comparison of EVLT and RFA  È²ÁøÈ£(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  11:25~12:05 Live Case 2 : Venaseal  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  12:05~12:15 During thermal ablation for SSV: Can various saphenopopliteal junctional anatomy be obstacles?  ±è¿ì½Ä(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 11-25  12:15~12:25 Can endovenous procedure replace surgery completely? When we consider surgery?  ¹Î½Â±â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-25  13:05~13:45 ¿ä¾ç±Þ¿© ¹× º¸Çè±Þ¿© Áö±Þ ¿ä°Ç¿¡ °üÇÑ Á¦¹Ý ¹ý·ü °ËÅä-ÇÏÁöÁ¤¸Æ·ù¼ö¼ú °ü·Ã »ç·Ê¸¦ Áß½ÉÀ¸·Î  ¼ÛºÀÁÖ(¹ý¹«¹ýÀÎ ¼¼Á¾) 
±³À°½Ã°£ 11-25  13:45~13:50 How glue works in vessel  ÀåÀϼö(¼ö¿µ»óÀÇÇÐ) 
±³À°½Ã°£ 11-25  13:50~14:00 What do we need to focus on before, during, and after Venaseal treatment?  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11-25  14:00~14:10 Can lower access for Venaseal reduce additional treatment for varicose tributaries  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  14:10~14:20 How does classic sclerotherapy work? Why does it fail to close the SV?  °øÁØÇõ(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-25  14:20~14:55 Live Case 3. : Clarivein  ¹Ú»ó¿ì,ȲÁøÈ£,¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  14:55~15:05 Mechanochemial ablation: What is difference from classic sclerotherapy and how to use it?  ±èº´±Õ(ºÎ»ê¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-25  15:05~15:15 Big match comes true: Venaseal vs Clarivein  À̽Âö(ÆíÇÑÇÏÁöÈäºÎ¿Ü°ú) 
È޽Ġ11-25  15:15~15:30 Coffee break  () 
±³À°½Ã°£ 11-25  15:30~15:40 Which vein is better for PICC insertion?  ¿ÀÇàÁø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-25  15:40~15:50 How do you select PICC catheter?  ½Éµ¿Àç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-25  15:50~16:00 What do we need to do to keep perm-cath to be used long as a last resort?  ±è¿ëÀç(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 11-25  16:00~16:10 How to manage chemoport related complications?  ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 11-25  16:10~16:20 Single Incision technique for chemoport: Can everyone do it? (Video presentation)  ¼Û¸í±Ô(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-25  16:20~16:30 Central venous occlusion during central venous catheter insertion: How to manage it  ¹Ú±Ù¸í(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 11-25  16:30~16:40 New PICC catheter development: KUH research result  ¾ç¿ì¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-25  16:40~16:50 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °Ç±¹´ëÇб³º´¿ø Konkuk Live Symposium: APECS, 2018 : 2018-11-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°³¿øÀÇÇùÀÇȸ Á¦22Â÷ Ã߰迬¼ö±³À° Çмú¼¼¹Ì³ª : 2018-11-25
´ÙÀ½±Û Á¦5ȸ ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2018-11-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
272 ¼­¿ï Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Á¤±âÇмú´ëȸ : 2018-09-17 0 449 2018-07-28
271 °æ±â Á¦ 1ȸ ¾ÆÁִ뺴¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-16 0 2,166 2018-07-28
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 607 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 951 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 851 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 692 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,448 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,232 2018-07-28
264 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 0 672 2018-07-28
263 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦2ȸ ÇÏÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-15 0 646 2018-07-28
262 Àü³² ¸ñÆ÷½ÃÀÇ»çȸ Çмú´ëȸ(°æµ¿¸Æ¼Õ»ó,°áÇÙ) : 2018-09-15 0 2,721 2018-07-28
261 ¼­¿ï °í·Á´ëÇб³ ½Å°æ°úÇб³½Ç ½ÉÆ÷Áö¿ò : 2018-09-15 0 1,978 2018-07-28
260 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÄÚºí·¹ÀÌÅ͸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ºñ°ú ¼ö¼úµé : 2018-09-15 0 773 2018-07-28
259 °æ±â Á¦6ȸ ÇѸ²´ëÇб³¼º½Éº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ½ÉÆ÷Áö¿ò : 2018-09-15 0 909 2018-07-28
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 655 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷